TLR9 signalling inhibits Plasmodium liver infection by macrophage activation

Area of Science:

• Immunology
• Infectious Diseases
• Parasitology

Background:

• Toll-like receptors (TLRs) are crucial for innate immunity, recognizing pathogen-associated molecular patterns (PAMPs).
• Plasmodium parasites, the causative agents of malaria, likely trigger TLRs during infection.
• The role of innate immune responses, particularly TLR signaling, in controlling Plasmodium liver-stage infection and subsequent blood-stage outcomes remains unclear.

Purpose of the Study:

• To investigate the impact of enhanced TLR signaling on Plasmodium infection.
• To determine stage-specific effects of TLR agonist priming on malaria progression.
• To explore potential therapeutic strategies for malaria based on TLR activation.

Main Methods:

• Utilized the Plasmodium berghei/C57Bl/6 murine malaria model.
• Administered TLR agonists to prime immune responses before sporozoite inoculation.
• Assessed the effects of TLR priming on liver-stage infection and experimental cerebral malaria (ECM).

Main Results:

• TLR9 agonist priming led to the elimination of pre-erythrocytic Plasmodium stages in the liver, dependent on macrophages and inducible nitric oxide synthase (iNOS).
• This represents a newly identified antigen-independent mechanism against liver-stage malaria.
• Priming with TLR4 and TLR9 agonists conferred protection against blood-stage infection, specifically reducing the severity of experimental cerebral malaria (ECM).

Conclusions:

• TLR signaling modulation can impact Plasmodium infection at different stages.
• Macrophage-mediated iNOS production is a key effector mechanism against liver-stage parasites following TLR9 activation.
• TLR activation holds promise for enhancing malaria vaccine efficacy, particularly concerning protection against severe outcomes like ECM.